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Transcription factors are important proteins that regulate gene expression and protein 
synthesis. Transcription factors can either boost the gene’s transcription rate by helping 
RNA polymerase activate transcription or restrict it by interfering with RNA polymerase, 
thereby repressing transcription. Nuclear factor-kappa-B (NF-κB) transcription factors 
are a family of proteins that control the synthesis of proteins involved in many cellular 
processes such as inflammatory and immune responses, cell growth, and apoptosis. 
However, the overexpression and activation of these transcription factors is linked to 
deadly conditions such as cancer and neurodegenerative diseases which currently have 
few safe cures. The goal of this research is to design and synthesize peptides to mimic the 
size, shape, structure and function of NF-κB. This will allow peptides to compete with 
and inhibit NF-κB from binding DNA, thus preventing the overexpression of proteins. To 
explore such possibilities, one peptide was analyzed. The binding affinity for between the 
peptide and κB DNA was determined using Isothermal Titration Calorimetry (ITC). The 
secondary structure of the peptide was determined using circular dichroism (CD). Initial 
data will direct the synthesis of new peptides that will show improved DNA binding 
affinity and will be screened for inhibition studies. A review of other β-sheet peptides is 
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Summary/Review of β sheet Peptides Section 
There are many different types of β-sheet DNA-binding proteins that play a vital 
role in the function of the body. NF-κB, for example, has the important role of regulating 
DNA transcription factors that in turn control gene expression and various cell processes 
vital to survival. Other important β-sheet DNA-binding proteins include replication 
protein A (RPA), xeroderma pigmentosum group A (XPA), X-ray repair cross-
complementing protein 4 (XRCC4), SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily A like 1 (SMARCAL1) protein, zinc finger RAN-
binding domain containing 3 (ZRANB3) protein, helicase-like transcrpition factor 
(HLTF) protein, and the proliferating cell nuclear antigen (PCNA) sliding clamp. 
RPA is a protein complex consisting of three subunits of approximately 70, 32, 
and 14 kDA each (heterotrimer) that each consist of α-helices (meaning a tendency 
towards methionine, alanine, leucine, glutamate, and lysine), a large number of β-sheets 
(meaning a tendency towards tyrosine, phenylalanine, tryptophan, threonine, valine, 
isoleucine, and proline), and loop regions (meaning a tendency towards tryptophan, 
phenylalanine, histidine, aspartate, tyrosine, leucine, glutamate, isoleucine, and valine). 
Using its six OB (Oligonucleotide/oligosaccharide-binding) folds, it mainly binds to 
single-stranded DNA (ssDNA) in a non-specific sequence manner in order to function in 
the role of DNA repair and is a major player in binding with other proteins involved in 
nucleotide excision repair (NER) (Flynn & Zou 267). Four of these OB folds are DNA-
binding domains on its β-sheets (three on RPA70 and one on RPA32) where the ssDNA 
binds to, with the amino acid tryptophan (W-101 in the RPA32 subunit DBD-D, for 
example) being the specific binding agent for the ssDNA to a loop region (Pohkrel 9414-
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9415). If the first binding domain on RPA70 (DBD-A) fails to bind the ssDNA due to 
disruption, it destroys RPA’s binding affinity to ssDNA, while point mutations in DBD-A 
or DBD-B or deletion of DBD-C just reduce said binding affinity. None of these 
disruptions affect its functionality in DNA replication, repair and checkpoint response, 
however, suggesting that RPA’s functions are not reliant on each other (Flynn & Zou 
267). 
XPA is a protein consisting of α-helices (meaning a tendency towards methionine, 
alanine, leucine, glutamate, and lysine), β-sheets (meaning a tendency towards tyrosine, 
phenylalanine, tryptophan, threonine, valine, isoleucine, and proline), and loop regions 
(meaning a tendency towards tryptophan, phenylalanine, histidine, aspartate, tyrosine, 
leucine, glutamate, isoleucine, and valine). XPA shares several visual characteristics with 
RPA aside from its much smaller size, but it prefers binding to branched DNA over linear 
DNA (Krasikova 2). Unlike RPA, XPA only has one DNA-binding domain in its central 
region, where it binds to DNA through the β-hairpin formed by β4-β5 specifically on 
residue Trp175, the antiparallel β-sheet (β3-β5) and the helix α2. In fact, two XPA 
molecules will work together to bind to a DNA duplex on either side (Lian 467-468). 
RPA and XPA are both close partners and important proteins in the NER process, where 
their binding to damaged DNA and other proteins trigger the activation of other proteins 
that repair DNA (Krasikova 2). 
 XRCC4 is an important protein in the process of specifically repairing DNA 
breaks. It mainly functions as a scaffolding protein for multiple non-homologous end-
joining (NHEJ) proteins such as XLF, DNA Ligase IV, APTX, and PNK. It is comprised 
of an N-terminal head domain (NTD), made up of a 7-stranded anti-parallel β sandwich 
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(meaning a tendency towards tyrosine, phenylalanine, tryptophan, threonine, valine, 
isoleucine, and proline), and a helix-turn-helix motif, which consists of two α helices 
(meaning a tendency towards methionine, alanine, leucine, glutamate, and lysine) joined 
by a short strand of amino acids. It also has an elongated, flexible α-helical coiled-coil 
region, and carboxyl termini tails which are phosphorylated by casein kinase II (CK2) 
that binds the necessary other proteins (Andres 13). However, for the interests of the 
protein-DNA interactions, only the NTD is of true interest, as this part of the protein is 
what binds to the structurally similar protein XRCC4-like factor (XLF). The bonding 
results in forming alternating chains of superhelical filaments that can bind to long 
double-stranded DNA substrates of over 100 base pairs via either grooves on the outside 
of the filament or through the central channel of the helices. The filament can then align 
broken or mismatched DNA end breaks for more efficient end processing and ligation 
(Andres 14). Overall, XRCC4 acts as an intermediary to the process of repairing DNA 
breaks via bonding to multiple proteins and the DNA rather than being a true initiator. 
 SMARCAL1 is a protein consisting of 954 amino acids and containing an RPA 
binding domain at the N-terminus followed by two HARP domains, and two lobed 
ATPase domains on the C-terminal half (Poole and Cortez 697). Its major purpose is to 
reanneal the complimentary strands of ssDNA bound by RPA and evict the latter protein, 
thus producing dsDNA. It does this in short bursts in order to in theory prevent excessive 
reannealing of the strands. Excessive reannealing would also interfere with 
SMARCAL1’s role in fork reversal, which is the process by which the replication “fork” 
created as the ssDNA strands combine back together undergoes in order to prevent 
replication stress from stalling production. This involves reannealing the parental and 
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nascent DNA strands to reverse the direction of the replication fork, which creates a 
“chicken foot” appearance when viewed (Poole and Cortez 698-699). The RPA binding 
domain on amino acid units 2-30 is necessary to interact with RPA subunit 32, which 
allows RPA to localize SMARCAL1 to the areas of replication stress and to either 
activate or inhibit its function as necessary (Poole and Cortez 701). The HARP domains 
on amino acid units 226-303 and 327-398 are the particularly important parts of the 
protein as they consist of a four-stranded anti-parallel β sheet (meaning a tendency 
towards tyrosine, phenylalanine, tryptophan, threonine, valine, isoleucine, and proline) 
decorated with two α helices (meaning a tendency towards methionine, alanine, leucine, 
glutamate, and lysine). Their purpose is to act as substrate recognition domains (SRDs) 
that confer DNA binding preference for junction DNA (Poole and Cortez 700). Without 
these, it would be impossible for them to do the job of reannealing the DNA. 
SMARCAL1 also bears a role in telomere replication through a similar manner (Poole 
and Cortez 704). Notably, however, SMARCAL1 does not bind DNA substrates 
composed entirely of ssDNA or dsDNA; however, it displays a strong preference for 
binding DNA substrates with a ssDNA/dsDNA junction (Poole and Cortez 699). 
 ZRANB3 is a 1079-amino acid protein and, based on sequence homology, is the 
most closely related SNF2 protein to SMARCAL1 (Poole and Cortez 705). It contains 
two lobed ATPase domains following each other on the N-terminus, followed by two 
protein interaction sites for PIP and NZF respectively, a SRD, a nuclease for HNH, and 
another protein interaction site for APIM on the C-terminus (Poole and Cortez 697). Like 
SMARCAL1 it has a strong preference for binding DNA substrates with a 
ssDNA/dsDNA junction while not binding to substrates composed entirely of ssDNA or 
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dsDNA, and it has an SRD like SMARCAL1’s HARP domains (Poole and Cortez 706). 
However, not only is this SRD on a different section of the protein at amino acids units 
621-650, it is heavily implied it has a similar but not identical structure to the HARP 
domains since while ZRANB3 functions in replication stress responses and fork 
remodeling just like SMARCAL1, it lacks SMARCAL1’s role in telomere replication 
and possesses endonuclease activity that depends on ATP hydrolysis by the intact motor 
domain and a C-terminal nuclease domain (Poole and Cortez 705-706). It has also been 
noted that ZRANB3 is localized to the areas of replication stress by its interactions with 
PCNA rather than RPA since it lacks a binding domain to the latter but does have them to 
the former via the PIP (PCNA-interacting protein), but the presence and absence of RPA 
can still affect whether or not fork reversal is inhibited (Poole and Cortez 707). 
 HLTF is a 1009-amino acid protein that contains a HIRAN domain that acts as its 
SRD at the N terminus, followed by two ATPase domains, and a RING domain between 
the two ATPase domains that acts as an E3 ubiquitin ligase (Poole and Cortez 697). The 
HIRAN domain consists of an arrangement of β sheets and α helices similar to the HARP 
domains of SMARCAL1 and the SRD of ZRANB3, but they are longer than the former 
in length (Poole and Cortez 700). Like SMARCAL1 and ZRANB3, HLTF binds to 
dsDNA with low affinity, but unlike them it will bind ssDNA and prefers binding to a 
replication fork-like structure due to how the HIRAN domain recognizes ssDNA with a 
preference for 3’ overhangs possessing a hydroxide group (3’-OH) (Poole and Cortez 
709). While it works in fork replication, it can only act in fork reversal rather than fork 
restoration, and as it lacks any RPA binding domain RPA seemingly has no effect on its 
regulation while PCNA presence does catalyze fork reversal (Poole and Cortez 710). 
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 PCNA is a ring-shaped homotrimer encircling the DNA helix whose purpose is to 
provide a moving platform for DNA polymerases and other proteins to dock for DNA 
replication and repair, and it can be considered the eukaryotic DNA sliding clamp 
equivalent of the bacterial β-clamp (March and Biasio 663). The clamp consists of two 
layers: an outer layer of six β-sheets and an inner layer of 12 α-helices lining the central 
channel, which is rich in lysine and arginine residues. The outer layer contains the 
protein-protein interaction sites, while the inner layer contains key basic residues that 
match to areas of the DNA’s double helix that allow it to recognize where on the DNA 
structure it is and in turn allow for rotational DNA backbone tracking and the clamp 
sliding along the helix as necessary, and these key residues cause the DNA to tilt and 
bend as it runs through the clamp to match with them (March and Biasio 663-665). The 
PCNA moves along DNA through two different modes of travel: transitional diffusion 
where PCNA travels along the DNA rapidly without making contact, and cogwheel 
diffusion where PCNA rotationally tracks the helical pitch of the DNA duplex through 
spiral motion, creating short-lived DNA interactions at a 30⁰ tilt to the clamp central axis 
that keep the clamp oriented. Cogwheel diffusion in particular is the most likely mode of 
PCNA sliding used during DNA replication, as it keeps the PCNA in the proper 
orientation to bind to the polymerase pol δ, which duplicates DNA, and also means there 
will always be an “active” spot ready to continue synthesis uninterrupted (March and 
Biasio 666-667). 
 These various proteins share several characteristics with each other in some form 
or another yet also bear differences. RPA and XPA obviously bear the most similarities 
to each other, since as previously mentioned XPA is structurally like RPA if smaller and 
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with only one DNA binding domain to RPA’s four. They both can play roles in many 
processes such as DNA replication, repair, and checkpoint response. The obvious 
difference is the fact that XPA has different binding preferences to RPA in that it prefers 
branched DNA to linear DNA, likely due to how it has fewer binding domains and its 
smaller size. XPA noticeably doesn’t rely on RPA for activation and instead works as a 
partner alongside it as necessary. 
XRCC4, meanwhile, is notably much different to RPA in terms of structure and 
function, particularly since its main role is as a scaffolding protein that acts solely in the 
process of mainly repairing DNA breaks rather than the many functions RPA and XPA 
do, and as a result it is much more specialized. After all, it needs to bind to the 
structurally similar XLF protein on its NTD with its anti-parallel β sandwich and helix 
turn helix motif first in order to make the filament able bind to DNA while RPA and 
XPA have no such issue, and even then it prefers binding to large sections of DNA while 
RPA and XPA have no such size restrictions. XRCC4 is not so much the initiator like 
RPA and XPA but rather the hub that serves to collect together the necessary proteins to 
prepare them for DNA binding. 
SMARCAL1 is also more specialized like XRCC4 but noticeable in how it works 
in conjecture with RPA to fulfill its functions of reannealing DNA, even having an RPA-
binding domain to react to the presence of the protein in question. Thus, SMARCAL1 
unlike the others could be considered something of a “follower” protein that responds to 
the process already in motion to fulfill its duty and thus can activated and stopped by 
RPA as required. The HARP domains of SMARCAL1 meanwhile are what bind to DNA 
as necessary, but as previously mentioned due to the different structure they have a 
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different preference for the kind of DNA they bind by preferring a combination of 
ssDNA and dsDNA rather than the branched DNA of XPA or the linear ssDNA 
preference of RPA. ZRANB3 meanwhile is very similar in structure to SMARCAL1 and 
bears many of the same functions and characteristics. One of the biggest differences, of 
course, is that since ZRANB3 lacks an RPA binding domain it’s regulated less directly 
by the protein than SMARCAL1 and in fact can act alongside SMARCAL1 in a manner 
like how RPA and XPA can work together where a deficiency of one doesn’t have a 
negative effect on the other and they can cover each other to an extent. HLTF meanwhile 
lacks an RPA binding domain and seemingly uninfluenced by RPA’s presence while like 
ZRANB3 it is still affected by PCNA, and the similar-yet-longer structure of its HIRAN 
domain also causes HLTF to only act in fork reversal rather than also fork restoration. 
Thus, the highly-similar structures with key differences allow them to have similar 
functions, but also their own unique roles that allow them to work mutually yet 
independently as necessary for the body. 
PCNA is like XRCC4 since binds DNA and other proteins on two different parts 
of its total structure and like XRCC4 acts as a “scaffolding” to allow proteins and DNA 
to properly bind. Where they differ is that PCNA binds to other proteins on its β sheet 
outer layer while it binds to DNA on its α helix inner layer before letting the two interact 
with each other. PCNA is also much more active than XRCC4 since it effectively acts as 
the major binding area for proteins and DNA. PCNA also aids in DNA replication and 
repair via being modulated by two different processes. The first is the acetylation of 
lysine residues on the inner layer of the sliding clamp, with certain residues degraded by 
certain proteins promoting the removal of chromatin-bound PCNA and its degradation in 
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NER, while the acetylation of other residues in response to DNA damage triggers 
homologous recombination suppresses cell sensitivity to the damaging agents. The 
second is interacting with the protein factor p15PAF, which bears a role in DNA 
replication and repair by binding to both the PCNA and directly to the DNA. This allows 
it to modulate PCNA sliding by forcing cogwheel diffusion over transitional diffusion 
due to binding DNA in the clamp to PCNA (March and Biasio 668-670). 
It’s noticeable that despite possessing many of the same secondary structures of β 
sheets and α helices, these proteins have much different roles in how they bind DNA and 
how that binding affects the necessary function they are carrying out. This in turn cuts to 
the heart of the matter that it is not merely the presence of secondary structures created by 
the specific amino acids of a protein that determines protein functionality and binding, 
but how those secondary structures are arranged in the protein to carry those out. 
Scientists in their attempts to understand and unlock the secrets of proper DNA-binding 
have had to observe the placement of these secondary structures and how they interact 
with each other and specific DNA sequences in order synthesize smaller proteins that can 
mimic just enough of the necessary structures to still bind the specific sequences without 
causing any resulting expression. In learning how to do this, scientists open up the 
possibility of being able to control the expression of proteins in a safe way that does not 
involve throwing the body’s natural balance of proteins out of order, but rather than be 
used to prevent overexpression and under-expression of certain proteins that results in 
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In order to properly analyze the sample peptide NF-κB WKWK (Ac-
QRFRWVRVNGKYIKVQLE-NH2) and how it interacts with annealed sample κB DNA 
combined with its complement (both 5’-TGG-GAA-TTC-CCA-3’), the processes of 
circular dichroism (CD) and isothermal titration calorimetry (ITC) were used. Circular 
dichroism is a method used to determine the secondary structures of peptides and protein, 
with noticeable dips and shifts at certain points on the wavelength indicating the presence 
of alpha helices, beta sheets, and random coils. Isothermal titration calorimetry is a 
technique used to study how small molecules bind to larger molecules by measuring the 
absorbance and release of heat during the binding process to determine the favorability of 
the reaction. For this research, CD was performed on the sample peptide NF-κB WKWK 
under various concentrations for each run in order to determine its potential secondary 
structures, and ITC was performed on the sample NF-κB WKWK and the annealed 
sample κB DNA combined with its complement over the course of three runs under 
various conditions. 
 
Figure 1: Sample peptide NF-κB WKWK (Ac-QRFRWVRVNGKYIKVQLE-NH2) 




 To begin the process of circular dichroism (CD), the researcher first opened the 
N2 gas cylinder via the regulator and let it run for 10 minutes. Once the time was up, they 
then turned on the “isotemp” device and set it to 25.00 ºC, adjusted the N2 cylinder air 
flow until it was approximately 120 kPa and 7-8 psi on the gauge, turned on the “Jasco 
MPTC-490S,” and finally turned on J-815 spectrometer itself. From the computer, they 
opened the “Spectra Manager” app before clicking on “Temperature Interval 
Measurement” in the menu. They connected the spectrometer via selecting the “Control” 
tab, then “Select Accessory” and “Auto-Peltier 6-cell Changer,” and then they selected 
the “Measure” tab and clicked “Baseline” to adjust all usable cells to the desired 
temperature of 25 ºC via selecting them all. 
Between the processes of letting the N2 run and allowing the cells to warm up, the 
researcher prepared the samples to run. Taking two cuvettes previously soaked in 
methanol, the researcher cleaned them out via at least six rinses with deionized water. 
One cuvette was filled with 400 µL of filtered 10 mM Na2HPO4 buffer (pH 7.02) to serve 
as the blank, while the other was filled with the sample peptide NF-κB WKWK (Ac-
QRFRWVRVNGKYIKVQLE-NH2). Said peptide was prepared via approximately 1.5 
mg peptide being dissolved in 1000 µL of buffer, with 400 µL transferred to another 
cuvette. The blank and sample were placed in Cells 1 and 2 respectively of the 
spectrometer once the cells were at the desired baseline temperature before being run 
through, while at the same time the researcher determined the concentration of the 
peptide through a UV-vis spectrometer (Genesys 50) with 20 µL of the remaining 
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sample. Once the data was run through, it was determined the concentration was too low 
and possibly even under 1.5 mg due to an insignificant dip at 210 nm. 
As there was very little of the peptide left in the container, the extra 580 µL was 
dumped back into the container and mixed to obtain a higher concentration determined 
through the UV-vis spectrometer once more with 10 µL of sample before repeating the 
CD run with 400 µL of the new sample. As the run determined the concentration was too 
high, the sample was divided in half with 200 µL of buffer being added to half of the 
sample to cut the concentration. When the next run still determined the concentration too 
high, 300 µL of peptide was taken and added with 100 µL of buffer to run again, and 
finally that result was divided in half and had 200 µL of buffer added to receive a final 
concentration. As the determined concentrations were subject to error due to the 
spectrometer and formula originally used, the concentration of the new peptide was 
determined via assuming the total amount of peptide in the container equaled 1.5 mg and 
worked from there, which was extrapolated to the following peptides to obtain their 
potential concentrations. As the curves proved binding, such concentrations could be 
guessed at since the experiment could be repeated with better measured concentrations. 
Calculations 
Calculation of Concentration for CD from UV-vis spectrometer (Genesys 50) 
w/Parameters: 200-400 nm; 2.0 nm; Fast 
𝐴 =∈∗ 𝑙 ∗ 𝑐 𝑤𝑖𝑡ℎ ∈= 230900
𝐿
𝑚𝑜𝑙 ∗ 𝑐𝑚
 𝑎𝑛𝑑 𝑙 = 1 𝑐𝑚 
Original Peptide Conc: 20 µL peptide, 380 µL buffer with an Abs at 250 nm of 0.012 
𝑐 =  
0.012
230900 ∗ 1
= 5.197 ∗ 10−8𝑀 ∗ 106 = 0.05197 𝜇𝑀 ∗
400 𝜇𝐿
20 𝜇𝐿
= 1.0394 𝜇𝑀 
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New Peptide Conc: 10 µL peptide, 390 µL buffer with an Abs at 250 nm of 0.056 
𝑐 =  
0.056
230900 ∗ 1
= 2.425 ∗ 10−7𝑀 ∗ 106 = 0.2425 𝜇𝑀 ∗
400 𝜇𝐿
10 𝜇𝐿
= 9.701 𝜇𝑀 
Calculation of Concentrations for CD from assumed amounts: 
New Peptide (assuming it contained 1.5 mg WKWK with Molar Weight of 2360.77 g): 
1.5 𝑚𝑔 𝑊𝐾𝑊𝐾 ∗ 
0.001 𝑔
1 𝑚𝑔
= 0.0015 𝑔 𝑊𝐾𝑊𝐾 ∗ 
1 𝑚𝑜𝑙
2360.77 𝑔
= 6.35 ∗ 10−7𝑚𝑜𝑙 
* If assuming the volume is the 580 µL (0.00058 L): 
6.35 ∗ 10−7𝑚𝑜𝑙
0.00058 𝐿
 =  0.001095493 𝑀 ∗ 106 = 1095.493 𝜇𝑀 
* If assuming the volume is 1000 µL (0.001 L): 
6.35 ∗ 10−7𝑚𝑜𝑙
0.001 𝐿
 =  6.35 ∗ 10−4 𝑀 ∗ 106 = 635.386 𝜇𝑀 
The assumed range of Concentration for the New Peptide was 635 to 1095 µM 
Old Peptide: Using the ratio between the values found on the UV-vis spectrometer… 
(635 𝑡𝑜 1095)𝜇𝑀 ∗
1.0394 𝜇𝑀
9.701 𝜇𝑀
= (66 𝑡𝑜 113)𝜇𝑀 
New Peptide #2 
(635 𝑡𝑜 1095)𝜇𝑀 ∗
200 𝜇𝐿
400 𝜇𝐿
= (318 𝑡𝑜 548)𝜇𝑀 
New Peptide #3 
(318 𝑡𝑜 548)𝜇𝑀 ∗
300 𝜇𝐿
400 𝜇𝐿
= (238 𝑡𝑜 411)𝜇𝑀 
New Peptide #4 
(238 𝑡𝑜 411)𝜇𝑀 ∗
200 𝜇𝐿
400 𝜇𝐿





Figure 2: CD spectrometer scan of Cell 1 “Buffer” containing 400 µL of 10 mM 
Na2HPO4, pH 7.02 (filtered) in first scan. 
 
 
Figure 3: CD spectrometer scan of Cell 2 “WKWK Hairpin” containing 400 µL of 66-






























Figure 4: CD spectrometer scan of Cell 2 “WKWK Hairpin” containing 400 µL of 635-
1095 µM WKWK peptide in second scan. 
 
 
Figure 5: CD spectrometer scan of Cell 2 “WKWK Hairpin” containing 400 µL of 318-

































Figure 6: CD spectrometer scan of Cell 2 “WKWK Hairpin” containing 400 µL of 238-
411 µM WKWK peptide in fourth scan. 
 
 
Figure 7: CD spectrometer scan of Cell 2 “WKWK Hairpin” containing 400 µL of 119-
































 For the CD runs, there was a dip in the graphs at 210-215 nm indicating there was 
a β-sheet in the peptide featured in Figure 1 even in the earliest stages as shown by Figure 
3, but it was too insignificant to be truly noteworthy. Increasing the concentration showed 
a much more noticeable dip in the same area as shown in Figure 4 and cutting the 
concentration down from there showed a smoother yet still obvious dip as shown by 
Figures 4-7. While exact concentrations of the peptide were subjective due to a failure to 
accurately log it before running the experiment, the obvious dip at the necessary 
wavelength at all runs indicated that the peptide did indeed have β-sheets and the process 
could be repeated effectively, so performing the experiment again with the same peptide 
after obtaining a proper concentration would indeed be possible. 
Isothermal titration calorimetry of NF-κB WKWK with annealed κB DNA and 
compliment 
Procedure 
 To begin the process of an isothermal titration calorimetry (ITC) run, the 
researcher first turned on the instrument and cleaned it. As each of the three runs was the 
first of the day, they used a Hamilton Syringe to put 300 mL of CONTAD 70 into the 
instrument’s cell before having the instrument run “Detergent Soak and Rinse (Long)” 
and following the needed prompts, which took approximately 40 minutes to run to 
completion before extracting and throwing the waste detergent away into the sink. While 
the instrument was being cleaned, the researcher prepared the sample peptide and DNA. 
The sample peptide was already pre-prepared in filtered ITC buffer 10 mM 
Na2HPO4 / 100 mM NaCl (pH 7.10) and its concentration found courtesy of the 
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NanoDrop in Protein A280 Mode (552.7 µM), which was then made into 500 µL of 5 
µM peptide in a 1500 µL micro-centrifuge tube. The sample double-stranded DNA κB 
DNA 2019 and its complement (both 5’-TGG-GAA-TTC-CCA-3’) were pre-prepared 
and annealed before their concentration was found in the NanoDrop in Nucleic Acid 
Mode (668.7 µM), which was then made into 60 µL of 500 µM DNA in a 100 µL micro-
centrifuge tube. 
Once the samples were ready and the instrument cleaned, the researcher went to 
the “Advanced Experimental Design” tab of the ITC, named the file 
(“WKWKtoDNA111419”), and set the Experimental Parameters (Total injections 20, 
Cell temperature (C) 25, Reference power (ucal/sec.)(0-12.65) 8, Initial delay (sec.) 60, 
Syringe Concentration (mM) 0.5, Cell Concentration (mM) 0.005, and Stirring speed 
(RPM) 750), and Injection Parameters (The first injection: Volume 0.4, duration 0.8, 
spacing 300, filter 5; all subsequent injections: Volume 2.0, duration 4.0, spacing 300, 
filter 5). They then loaded the DNA tube into the “load” area on the instrument, set the 
syringe to the rest position with the tube hooked up and selected “Syringe Fill” under the 
“Instrument Controls” tab to follow the directions of loading the DNA into the syringe. 
Once completed, they took the Hamilton syringe and cleaned it once with 
methanol and twice with ITC buffer before drawing up 350 µL of the peptide sample and 
removing bubbles from the mixture before injecting it to fill the instrument cell. Once 
finished, they tapped around inside the cell to loosen and pop any spare bubbles before 
cleaning the Hamilton syringe with methanol and moving the filled DNA syringe into its 
rest position. They then removed the tube attached to the syringe and connected it to the 
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back of the instrument before firmly but carefully inserting the syringe into the cell and 
clicking “Start” to run the experiment through its baseline and the run proper. 
After approximately two hours, the run was completed, and the file was analyzed 
in “MicroCal Analysis Launcher ITC200.” The run was then repeated but with a reduced 
DNA concentration from 500 µM to 350 µM (“WKWKtoDNA120419”), and then that 
run was repeated with the same changed concentration but with the temperature increased 
from 25 ºC to 30 ºC and a different filtered ITC buffer (“WKWKtoDNA120519”). 
Calculations 
Calculation of Concentrations for ITC Runs 
Calculation of Peptide Concentration from Average NanoDrop Protein A280 w/ “5M 
GuHCl & Peptide” (83 µL of 2.5 mg/mL peptide in 500 µL of solution) and Molar 












= 552.7 𝜇𝑀 
Calculation of DNA Concentration of both KB DNA and its complement (814.5 + 893.9 
nmol mixed together with 815 + 894 µL of 10mM Na2HPO4 / 100 mM NaCl) from 
Average ng/µL NanoDrop Nucleic Acid Mode (Conc Factor 62.80) and Molar Weight 
















= 668.7 𝜇𝑀 
Peptide and DNA Concentrations for “WKWKtoDNA111419” 
• Peptide: (552.7 𝜇𝑀)(𝑥 𝜇𝐿) = (5 𝜇𝑀)(500 𝜇𝐿) → 𝑥 𝜇𝐿 = 4.5 𝜇𝐿 →
5 𝜇𝐿 𝑝𝑒𝑝𝑡𝑖𝑑𝑒, 495 𝜇𝐿 𝐼𝑇𝐶 𝑏𝑢𝑓𝑓𝑒𝑟 
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• DNA: (668.7 𝜇𝑀)(𝑥 𝜇𝐿) = (500 𝜇𝑀)(600 𝜇𝐿) → 𝑥 𝜇𝐿 = 44.86 𝜇𝐿 →
45 𝜇𝐿 𝐷𝑁𝐴, 15 𝜇𝐿 𝐼𝑇𝐶 𝑏𝑢𝑓𝑓𝑒𝑟 
Peptide and DNA Concentrations for “WKWKtoDNA120419” 
• Peptide: (552.7 𝜇𝑀)(𝑥 𝜇𝐿) = (5 𝜇𝑀)(500 𝜇𝐿) → 𝑥 𝜇𝐿 = 4.5 𝜇𝐿 →
5 𝜇𝐿 𝑝𝑒𝑝𝑡𝑖𝑑𝑒, 495 𝜇𝐿 𝐼𝑇𝐶 𝑏𝑢𝑓𝑓𝑒𝑟 
• DNA: (668.7 𝜇𝑀)(𝑥 𝜇𝐿) = (350 𝜇𝑀)(600 𝜇𝐿) → 𝑥 𝜇𝐿 = 31.40 𝜇𝐿 →
31 𝜇𝐿 𝐷𝑁𝐴, 29 𝜇𝐿 𝐼𝑇𝐶 𝑏𝑢𝑓𝑓𝑒𝑟 
Peptide and DNA Concentrations for “WKWKtoDNA120519” 
• Peptide: (552.7 𝜇𝑀)(𝑥 𝜇𝐿) = (5 𝜇𝑀)(500 𝜇𝐿) → 𝑥 𝜇𝐿 = 4.5 𝜇𝐿 →
5 𝜇𝐿 𝑝𝑒𝑝𝑡𝑖𝑑𝑒, 495 𝜇𝐿 𝐼𝑇𝐶 𝑏𝑢𝑓𝑓𝑒𝑟 
• DNA: (668.7 𝜇𝑀)(𝑥 𝜇𝐿) = (500 𝜇𝑀)(600 𝜇𝐿) → 𝑥 𝜇𝐿 = 31.40 𝜇𝐿 →
31 𝜇𝐿 𝐷𝑁𝐴, 29 𝜇𝐿 𝐼𝑇𝐶 𝑏𝑢𝑓𝑓𝑒𝑟 
Results 
Table 1: Comparison of the equilibrium association constants (Ka) and equilibrium 
dissociation constants (Kd) across the ITC runs. The number of data points removed from 
the original runs for being assumed as “bad data” to generate the altered runs are listed. 
File Run Ka (M
-1) Kd (1/Ka) (M) 
11/14/19 Original 5.03E4 ± 6.44E4 1.99E-5 ± 1.55E-5 
11/14/19 Altered (1 Pt) 1.18E4 ± 3.50E4 8.47E-5 ± 2.86E-5 
12/04/19 Original 6.22E5 ± 1.86E6 1.61E-6 ± 5.38E-7 
12/04/19 Altered (3 Pts) 1.25E5 ± 1.45E5 8.00E-6 ± 6.90E-6 
12/05/19 Original 5.14E3 ± 4.92E4 1.94E-4 ± 2.03E-5 





Figure 8: Original ITC run “WKWKtoDNA111419.” 
 




Figure 10: Original ITC run “WKWKtoDNA120419.” 
 




Figure 12: Original ITC run “WKWKtoDNA120519.” 
 
 




For the ITC runs, the major goals were to have the points close together, to have 
the trend line possess a noticeable exponential decay trend, and to obtain a low-enough 
Kd on the line to indicate proper binding of the peptide with the DNA, with that range 
being preferably in the low micro-molar scale. As shown in Figures 8 and 9, the runs on 
12/04/19 did possess the desired exponential decay, but the points were further apart from 
each other and the Kd values were larger than desired as can be seen in Table 1. Lowering 
the DNA concentration, as shown in Figures 10 and 11, showed marked improvement in 
all desired areas with closer-together points, a more obvious decay, and even pulled the 
Kd values into the desired micro-molar range as shown in Table 1. The runs on 12/05/19, 
as shown in Figures 12 and 13 and Table 1, pulled back on that somewhat, but they were 
still better than the runs on 11/14/19 with more obvious decay and closer-together points. 
While some of the changes might be attributed to the increase in temperature, there was 
also the possibility of the different filtered ITC buffer being a factor since the original 
was frozen and could not be used. Improvements on the process could still be made 
possible, however, with the standardization of the types of buffer to be used across runs 
and better accustomization to the process decreasing the chances of human error. 
Overall Conclusions 
 As shown in both the CD and ITC, the sample peptide NF-κB WKWK possesses 
many of the desired traits wanted in a protein that binds NF-κB DNA. The CD shows the 
dip at the necessary wavelength to indicate presence of the β sheet secondary structures 
required. The ITC meanwhile shows there is definite bonding between the WKWK 
peptide and the κB DNA due to the Kd values on display, though more testing and better 
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conditions would certainly be required to get better answers. From this data, it would be 
prudent to create other peptides with similar structures to NF-κB WKWK to compare 
their binding affinity to κB DNA. 
 
 
 
 
 
